SureTrader Nadex Advertisement PGUS
Home > Boards > US Listed > Medical - Healthcare >

Gilead Sciences, Inc. (GILD)

GILD RSS Feed
Add GILD Price Alert      Hide Sticky   Hide Intro
Moderator: mick, DewDiligence, wshaw14
Search This Board: 
Last Post: 3/25/2017 8:26:07 PM - Followers: 111 - Board type: Free - Posts Today: 0


GILD Investor Relations

http://www.otcmarkets.com/stock/GILD/quote
http://www.otcmarkets.com/stock/GILD/profile
Contact Info
  • 333 Lakeside Drive
    Foster City, CA 94404
GILD Security Details
Share Structure
  Market Value1 $94,343,029,244 a/o Dec 30, 2016
  Authorized Shares Not Available
  Outstanding Shares 1,317,456,071 a/o Oct 31, 2016
  -Restricted Not Available
  -Unrestricted Not Available
  Held at DTC Not Available
  Float Not Available
  Par Value 0.001
Transfer Agent(s)
BNYMellon Shareowner Services
Shareholders
Shareholders of Record 363 a/o Feb 24, 2016
Corporate Actions
  Ex. Date Record Date Pay Date
Dividend (0.47) Dec 13, 2016 Dec 15, 2016 Dec 29, 2016
Dividend (0.47) Sep 14, 2016 Sep 16, 2016 Sep 29, 2016
Dividend (0.47) Jun 14, 2016 Jun 16, 2016 Jun 29, 2016
 
Dividends are not adjusted for stock splits
Security Notes
  • Capital Change=shs increased by 2 for 1 split. Ex-date=03/08/2002. Rec date=02/14/2002. Pay date=03/07/2002.
    Latest Addt'l Issue=2-96 4,000,000 shs at $37.75 by Robertson, Stephens & Co. et al.
    New Issue=1-92 5,000,000 shs at $15 by Robertson, Stephens & Co., et al.
    Capital Change=shs increased by 2 for 1 split. Ex-date=02/22/2001. Rec date=02/02/2001. Pay date=02/21/2001.
    Capital Change=shs increased by 2 for 1 split. Ex-date=09/07/2004. Rec date=08/12/2004. Pay date=09/03/2004.
    Capital Change=shs increased by 2 for 1 split Ex-date=06/25/2007. Rec date=05/24/2007. Pay date=06/22/2007.
    Capital Change=shs increased by 2 for 1 split. Ex-date=01/28/2013. Rec date=01/07/2013. Pay date=01/25/2013.

    http://finviz.com/quote.ashx?t=GILD&ty=c&ta=1&p=d
    http://finviz.com/ ;



  •  
***DISCLAIMER***
-  The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
-  We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
-  There are no guarantees when buying or selling any security.









     
 
Short Selling Data
Short Interest 19,440,457 (-7.51%)
Nov 30, 2010
Significant Failures to Deliver No


 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
GILD
Current Price
Volume:
Bid Ask Day's Range
SureTrader
GILD News: British Columbia lists EPCLUSA™ on public drug plan to treat all six genotypes of chronic hepatitis C infection 03/21/2017 04:00:00 PM
GILD News: EPCLUSA(MC), premier traitement pour les six génotypes de l'infection chronique par l'hépatite C, ajouté à la Liste des m... 03/20/2017 12:28:00 PM
GILD News: EPCLUSA™, to treat all six genotypes of chronic hepatitis C infection, added to the Liste des médicaments de la RAMQ 03/20/2017 12:25:00 PM
GILD News: Statement of Changes in Beneficial Ownership (4) 03/03/2017 06:30:33 PM
GILD News: Statement of Changes in Beneficial Ownership (4) 03/03/2017 06:04:59 PM
PostSubject
#2444  Sticky Note After tough year, 9 questions for Gilead mick 01/03/17 02:27:26 PM
#2436  Sticky Note More on same topic—(MRK-GILD patent case): #msg-127266273. DewDiligence 12/17/16 10:47:08 AM
#2580   GILD News: British Columbia lists EPCLUSA™ on public mick 03/25/17 08:26:07 PM
#2579   Gilead Sciences, Inc (GILD) mick 03/25/17 08:26:00 PM
#2578   What's the deal with the sp why is 123boom 03/24/17 04:29:35 PM
#2577   Thanks for the info. I will leave all wshaw14 03/24/17 04:16:45 PM
#2576   Kite's methodology still has some very serious shortcomings..It's shub 03/24/17 03:08:53 PM
#2575   I have not seen any rumors on that wshaw14 03/20/17 07:43:54 PM
#2574   Rumors on INCYTE and Kite..Nothing on CYDY!Y pearsby09 03/20/17 06:32:12 PM
#2573   I have also been seeing rumors about GILD wshaw14 03/17/17 04:20:56 PM
#2572   Gilead Beats $50M Drug Bonus Call In Del wshaw14 03/15/17 07:47:00 PM
#2571   More on the rumor wshaw14 03/15/17 07:44:32 PM
#2570   Gilead Sciences (GILD) Presents at Barclays Healthcare Conference wshaw14 03/14/17 05:32:48 PM
#2569   New Tenofovir Prodrug Is Noninferior to Currently Used Prodrug wshaw14 03/14/17 01:00:42 AM
#2568   I dont know how true the rumor is, wshaw14 03/13/17 12:57:25 AM
#2567   GILD buying INCY? Any truth to this? fl89808 03/10/17 04:26:58 PM
#2566   gotta go lower first Fibanotch 03/09/17 10:07:53 AM
#2565   Lol, 100s could be on the way also. wshaw14 03/08/17 03:19:00 PM
#2564   5o's could be on the way Fibanotch 03/08/17 10:24:18 AM
#2563   forward p/e is 9 and change...a buy here... ~Gordo~ 03/04/17 05:18:10 PM
#2562   GILD cheap p/e ttm 7...dividend is 3%, pretty ~Gordo~ 03/04/17 05:11:57 PM
#2561   Out GILD @ $70.75 at the EOD. chmcnfunds 03/03/17 04:08:30 PM
#2560   Lot of good info in that article -- thanks. chmcnfunds 03/01/17 09:02:15 AM
#2559   That other location you hit up a bit eventhelosers 02/28/17 05:10:07 PM
#2557   Gilead: Buy The HIV Franchise And Get The wshaw14 02/28/17 03:30:07 PM
#2556   Rumors that Starboard is in Gilead. chmcnfunds 02/28/17 11:29:54 AM
#2554   Got it. Thanks for the reply. LongRun8 02/25/17 11:00:18 PM
#2553   Thanks for the information Dew, much appreciated. BlackDoggie 02/25/17 07:45:59 PM
#2551   ANYONE have any potential 10 baggers in the pearsby09 02/25/17 02:09:57 PM
#2550   ...if multiple classes of ART fails?Treatment failure has DewDiligence 02/25/17 11:38:46 AM
#2549   Yeah, who needs pro-140 if multiple classes of buckysherm 02/25/17 11:23:00 AM
#2548   GILD already has three TAF-based products on the DewDiligence 02/25/17 10:44:25 AM
#2547   I went to GILEAD's Pipeline page...looks like you pearsby09 02/25/17 10:30:49 AM
#2546   Excuse my ignorance, but are the TAF-Based regimens pearsby09 02/25/17 10:25:43 AM
#2545   Viread and Truvada are going off-patent soon (they DewDiligence 02/25/17 10:17:27 AM
#2544   I thought GILD was losing two of their pearsby09 02/25/17 10:08:05 AM
#2543   Gilead, AbbVie Could Perk Up On Merck's Hep wshaw14 02/24/17 10:48:29 PM
#2542   Same as yours, opposite of chmcnfunds, see #2505- #2512 north40000 02/24/17 08:45:57 PM
#2541   What was your position? TIA. LongRun8 02/24/17 08:28:01 PM
#2540   Could be, and I would think that there BlackDoggie 02/24/17 02:22:21 PM
#2539   I think cydy would be a nice fit 123boom 02/24/17 02:19:45 PM
#2538   GILD's HIV franchise is pretty much set in DewDiligence 02/24/17 02:15:10 PM
#2537   Charlie Sheen has been taking pro140 with out 123boom 02/24/17 02:07:41 PM
#2536   BTD (if PRO 140 gets it) is no DewDiligence 02/24/17 01:59:58 PM
#2535   HIV patients are suited for a CCR5 agent DewDiligence 02/24/17 01:56:38 PM
#2534   Mr. Dew I encourage you to do some 123boom 02/24/17 01:51:55 PM
#2533   Interesting - thanks for the response and the BlackDoggie 02/24/17 01:30:04 PM
#2532   Doubtful, IMO. CYDY’s PRO 140, at best, addresses DewDiligence 02/24/17 01:07:06 PM
#2531   interesting Fibanotch 02/24/17 08:53:23 AM
#2530   With all of the acquisition talk on this BlackDoggie 02/23/17 06:00:39 PM
#2529   Gilead Sciences, Inc. (NASDAQ:GILD) EPCLUSA Access To Be trendmkr 02/23/17 02:12:19 PM
#2528   Bingo, a use for the voucher: chmcnfunds 02/23/17 07:35:17 AM
PostSubject